The global outsourced orthopedic manufacturing market is likely to grow from 2016 to 2020, according to a Technavio report.
Spinal Tech
Moody's Investors Service has placed Stryker's A3 unsecured note ratings on review for downgrade, on the heels of the news that Stryker plans to acquire Sage Products for approximately $2.7 billion.
Bone Therapeutics has extended its collaboration with Kasios, a synthetic bone substitute specialist.
All eight Medicare Administrative Contractors have confirmed coverage for the treatment of chronic wounds with Osiris Therapeutics' Grafix.
TranS1 named Chris Groppa as chief marketing officer and director of reimbursement.
Advertisement
Zimmer Biomet net sales were up for the 2015 full year.
Smith & Nephew CEO Olivier Bohuon was diagnosed with cancer.
Stryker acquired Sage Products from Madison Dearborn Partners for $2.7 billion.
Jonathan S. Lewin, MD, is the first surgeon in New Jersey to adopt the FLXfit articulated and lordotic expandable cage as his choice of treatment for MIS transforaminal lumbar interbody fusion surgery.
Amedica stock rose by 76.22 percent in the past week, according to a Wall Street Prudent report.